bioMT Pilot Project Program: Call for Proposals! Submission deadline: October 12, 2018.
For more information, including application instructions, visit: bit.ly/biomtpilot
What We Do
We explore the operation and control phosphorylation and protein-protein interaction networks, conformational switches, microRNA regulatory pathways, and intracellular trafficking and degradation machineries.
We accelerate the research and career trajectories of students, post-docs, and junior faculty members.
We seek new therapeutic targets for brain cancer, colon cancer, pancreatic cancer, airway infection, and inflammation.
We integrate insights from protein biochemistry and engineering, biophysics, high-resolution microscopy, and chemical, structural and computational biology.
Who We Are
60 scientists • 15 labs • 10 departments • 3 schools
We are looking to grow! Our labs welcome students through the MCB, PEMM, QBS, Chemistry, and Computer Science graduate programs. We welcome applications from outstanding post-doctoral fellows on an on-going basis. We are also partnering across campus to launch a series of faculty searches over the next five years.
Funding is provided by award P20-GM113132 from the IDeA program of the NIH National Institute of General Medical Sciences, Dartmouth College, the Geisel School of Medicine, the Thayer School of Engineering, and the Norris Cotton Cancer Center.
We also work closely with the Digital Arts, Leadership & Innovation (DALI) Lab, the Dartmouth Entrepreneurial Network (DEN), other IDeA Programs at Dartmouth (immunology, Lung Biology, Molecular Epidemiology, and Quantitative Biology COBRE programs and NH-INBRE) and across New England (Vermont Genetics Network and Maine INBRE).